ZAI LAB LIMITED Shares Outstanding (Cover Page)
ZAI LAB LIMITED (ZLAB) had Shares Outstanding (Cover Page) of 88.59 million shares as of 2021-02-26, per its 10-K filed 2021-03-01.
Discontinued › Notes
dei:EntityCommonStockSharesOutstanding · last filed 2021-03-01
- 2021-02-26: Entity Common Stock, Shares Outstanding 88.59M shares.
- 2019-12-31: Entity Common Stock, Shares Outstanding 68.38M shares.
- 2018-12-31: Entity Common Stock, Shares Outstanding 58.36M shares.
- 2017-12-31: Entity Common Stock, Shares Outstanding 50.56M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2021-02-26 | 88.59M shares 10-K · filed 2021-03-01 |
| 2019-12-31 | 68.38M shares 20-F · filed 2020-04-29 |
| 2018-12-31 | 58.36M shares 20-F · filed 2019-03-29 |
| 2017-12-31 | 50.56M shares 20-F · filed 2018-04-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |